Study identifier:D3120C00006
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A Randomised, Double Blind, Placebo-Controlled Study to Investigate the Analgesic Efficacy of a Single Dose of AZD1940, in Patients Undergoing Impacted Mandibular Third Molar Extraction
Pain
Phase 2
Yes
AZD1940, Naproxen, Placebo
All
151
Interventional
18 Years - 45 Years
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment
Verified 01 May 2010 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|---|
Experimental: AZD1940 AZD1940 800ug given predose | Drug: AZD1940 800ug oral administration |
Active Comparator: Naproxen Naproxen 500mg given pre-surgery | Drug: Naproxen 500mg oral administration Other Name: Naprosyn |
Placebo Comparator: Placebo Placebo given pre-surgery | Drug: Placebo Placebo given pre-surgery |